Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cottone

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Journal of Crohn'S & Colitis|April 30, 2016
The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?Fabio Salvatore Macaluso, Mario Cottone, Ambrogio Orlando
World Journal of Gastroenterology|August 29, 2006
Cytomegalovirus and inflammatory bowel disease: is there a link?Valeria Criscuoli, Maria-Rosa Rizzuto, Mario Cottone
Inflammatory Bowel Diseases|October 3, 2006
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic responseIrene Modesto, Daniela Scimeca, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|August 29, 2009
Oral valganciclovir for colonic dilatation in ulcerative colitis associated with human cytomegalovirus infectionValeria Criscuoli, Stefania Plano, Emma Aragona, et al.
Recenti Progressi in Medicina|November 30, 2007
[Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]Filippo Mocciaro, Ambrogio Orlando, Daniela Scimeca, et al.
Lancet (London, England)|November 22, 2002
Maintenance infliximab for Crohn's diseaseMario Cottone, Ambrogio Orlando, Angelo Casà, et al.
Expert Opinion on Pharmacotherapy|October 13, 2011
Medical management of Crohn's diseaseMario Cottone, Sara Renna, Ambrogio Orlando, et al.
European Journal of Internal Medicine|September 29, 2009
Placebo therapy in Crohn's diseaseSara Renna, Ambrogio Orlando, Filippo Mocciaro, et al.
European Journal of Internal Medicine|January 22, 2013
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseasesEmanuele Sinagra, Giovanni Perricone, Claudia Romano, et al.
Expert Opinion on Pharmacotherapy|June 18, 2013
Mesalazine for the treatment of inflammatory bowel diseaseValeria Criscuoli, Irene Modesto, Ambrogio Orlando, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Journal of Crohn'S & Colitis|April 30, 2016
The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?Fabio Salvatore Macaluso, Mario Cottone, Ambrogio Orlando
World Journal of Gastroenterology|August 29, 2006
Cytomegalovirus and inflammatory bowel disease: is there a link?Valeria Criscuoli, Maria-Rosa Rizzuto, Mario Cottone
Inflammatory Bowel Diseases|October 3, 2006
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic responseIrene Modesto, Daniela Scimeca, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|August 29, 2009
Oral valganciclovir for colonic dilatation in ulcerative colitis associated with human cytomegalovirus infectionValeria Criscuoli, Stefania Plano, Emma Aragona, et al.
Recenti Progressi in Medicina|November 30, 2007
[Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]Filippo Mocciaro, Ambrogio Orlando, Daniela Scimeca, et al.
Lancet (London, England)|November 22, 2002
Maintenance infliximab for Crohn's diseaseMario Cottone, Ambrogio Orlando, Angelo Casà, et al.
Expert Opinion on Pharmacotherapy|October 13, 2011
Medical management of Crohn's diseaseMario Cottone, Sara Renna, Ambrogio Orlando, et al.
European Journal of Internal Medicine|September 29, 2009
Placebo therapy in Crohn's diseaseSara Renna, Ambrogio Orlando, Filippo Mocciaro, et al.
European Journal of Internal Medicine|January 22, 2013
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseasesEmanuele Sinagra, Giovanni Perricone, Claudia Romano, et al.
Expert Opinion on Pharmacotherapy|June 18, 2013
Mesalazine for the treatment of inflammatory bowel diseaseValeria Criscuoli, Irene Modesto, Ambrogio Orlando, et al.
Pageof 12